“According to the research report, the global irritable bowel syndrome (IBS) treatment market was valued at USD 3.69 billion in 2023 and is expected to reach USD 7.60 billion by 2032, to grow at a CAGR of 8.4% during the forecast period.” Industry Overview The careful analysis and meticulous efforts of expert analysts, skilled researchers, and professional forecasters have...